CMMB

Chemomab Therapeutics
CMMB

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $3.11M invested in Chemomab Therapeutics in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.36M
2
+$679K
3
+$411K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$288K
5
MIH
Meitav Investment House
Israel
+$177K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.36M
2
$679K
3
$411K
4
$288K
5
$177K
6
$176K
7
$19K
8
$3K